Bosh sahifaILMN • SWX
add
Illumina Inc
Bozor kapitalizatsiyasi
22,00 mlrd USD
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,08 mlrd | 0,37% |
Joriy xarajat | 517,00 mln | -6,17% |
Sof foyda | 150,00 mln | -78,72% |
Sof foyda marjasi | 13,84 | -78,80% |
Har bir ulushga tushum | 1,34 | 17,54% |
EBITDA | 299,00 mln | 6,79% |
Amaldagi soliq stavkasi | 31,82% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,28 mlrd | 36,10% |
Jami aktivlari | 6,18 mlrd | 2,71% |
Jami passivlari | 3,80 mlrd | -2,39% |
Umumiy kapital | 2,38 mlrd | — |
Tarqatilgan aksiyalar | 152,80 mln | — |
Narxi/balansdagi bahosi | — | — |
Aktivlardan daromad | 9,46% | — |
Kapitaldan daromad | 11,82% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 150,00 mln | -78,72% |
Operatsiyalardan naqd pul | 284,00 mln | -10,13% |
Sarmoyadan naqd pul | -51,00 mln | -24,39% |
Moliyadan naqd pul | -115,00 mln | 65,36% |
Naqd pulning sof oʻzgarishi | 116,00 mln | 327,45% |
Boʻsh pul | 213,38 mln | 193,08% |
Haqida
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
Tashkil etilgan
1998
Sayt
Xodimlar soni
9 000
